|Description||CDN 1163 is an allosteric activator of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2), increasing Ca2+-ATPase activity and Ca2+ uptake by ER microsomes from obese mice. It reduces fasting glucose levels and adipose tissue weight, and increases energy expenditure in ob/ob mice. CDN 1163 has the potential to treat type-2 diabetes and metabolic dysfunction.|
|Brife Description||SERCA2 activator|
|Purity||≥98% by HPLC|
|Synonyms||CDN-1163; CDN 1163; CDN1163; 4-(1-Methylethoxy)-N-(2-methyl-8-quinolinyl)benzamide; 4-Isopropoxy-N-(2-methylquinolin-8-yl)benzamide|
SPDP is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide...
Carnosic acid has medicinal properties, is a potent antioxidant and protects skin cells against UV-A radiation (photoprotection). Studies in animals have also f...
DiZPK, a photocrosslinking amino acid, could be significant in revealling the physiological and functions of some proteins acting as a genetically encoded.
Cot inhibitor-2 is a COT/Tpl2 inhibitor.
4-(Aminomethyl)benzoic Acid, an unnatural amino acid derivative, is a type 2 antifibrinolytic agent,
PBP 10 is a selective formyl peptide receptor 2 (FPR2) antagonist. It exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK ...
TMPA is an antagonist of nuclear receptor Nur77 (Kd = 1.45 ± 0.35 μM) and LKB1 interaction.
Brassinolide is a plant sterol first isolated from pollen of rape (Brassica napus L.). It could promote stem elongation and cell division.